AlbionVC

What AlbionVC does

AlbionVC is the technology investment arm of Albion Capital Group LLP, a London-based venture capital firm founded in 1996 that backs early-stage software, healthcare, and deeptech companies, primarily in the United Kingdom with selective exposure to Europe and North America. The firm operates predominantly through UK Venture Capital Trust (VCT) products targeted at retail and institutional investors, complemented by thematic vehicles including the UCL Technology Fund managed in partnership with UCL Business. The disclosed portfolio spans artificial intelligence and decision-intelligence (Quantexa, tem), digital assets and blockchain analytics (Elliptic, Agio Ratings, OpenTrade), healthtech (Oviva, GiveVision, Moodbeam), climate tech (Treefera, Gigaton, Mondra), quantum computing (Phasecraft), and API infrastructure (Gravitee), with reported aggregate outcomes of 5,170+ jobs created and 780,000+ patient outcomes delivered.

The firm generates revenue through management fees on its approximately £715 million portfolio of assets and carried interest on successful exits, targeting a 5% NAV dividend yield for VCT investors. Its investment proposition centres on long-duration capital, sector-focused thematic expertise, and operational GTM support that has reportedly underpinned 55+ C-level hires across portfolio companies; founder engagement is tracked via a reported Net Promoter Score of 81. Capital deployment is paced through annual VCT raises (e.g., £84m in 2024, £90m fully subscribed in 2026) and selective participation in follow-on rounds such as Elliptic's $120M Series D, with the Egress sale to KnowBe4 in 2024 standing out as a recent realised exit.

AlbionVC's go-to-market combines direct founder outreach, a university spinout pipeline anchored by the UCL partnership, content-led demand generation through sector reports (European Digital Assets, European HealthTech Market Map, DeepTech & Future of Compute), and community programs including the Radia Accelerator for women founders and the Harley Street Health District partnership. The firm is small by headcount (11-50 employees) and recently expanded senior capacity through four partner promotions in 2024 and continued thematic hiring such as Lucia Rodriguez Lacasa's April 2026 appointment to the healthtech team.

Name

AlbionVC

Legal name

Albion Capital Group LLP

Website

https://albion.vc

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

11–50 employees

Short description

AlbionVC is the technology investment arm of Albion Capital Group LLP, a London-based venture capital firm founded in 1996 that invests in early-stage UK software, healthcare, and deeptech companies through VCT products and thematic funds including the UCL Technology Fund.

Ownership category

akta.pro rank

Product category

Venture Capital

akta.pro primary industry

Venture Capital Fund-of-Funds / Multi-Manager Platforms (FSANAAAJ)

akta.pro secondary industry

Venture Capital Fund-of-Funds (FSANAGAC)

Keywords

• Venture capital funding
• Early-stage technology
• Healthcare venture capital
• Deeptech startup investment
• University spinout funding

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Venture Capital Fund Management: AlbionVC generates returns through management fees and carried interest from their venture capital funds, including VCT (Venture Capital Trust) products and technology-focused funds. They manage the UCL Technology Fund in collaboration with UCL Business and have raised multiple funding rounds including an £84m raise in 2024.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

AlbionVC is the technology investment arm of Albion Capital Group LLP, providing long-term venture capital funding and scale-up expertise to early-stage UK software, healthcare, and deeptech companies. The firm raises and manages Venture Capital Trust (VCT) funds for retail and institutional investors, manages the UCL Technology Fund in collaboration with UCL Business, and supports founders with operational and GTM advisory services through its sector-specialist partner team.

Product overview

AlbionVC operates as a venture capital firm focused on early-stage software, healthcare, and deeptech companies. The firm provides sector newsletters covering DeepTech, FinTech, HealthTech, and General VC topics, allowing subscribers to stay informed about portfolio news, market insights, and investment perspectives. Beyond newsletters, AlbionVC offers access to sector-specific deep dives, market maps, and reports including the Digital Assets Report, European HealthTech Market Map, and DeepTech & Future of Compute Report.

Differentiator

Problem solved

Functional benefit

Brands

• UCL Technology Fund: A university technology fund managed by AlbionVC in collaboration with UCL Business, focused on UCL spinouts and technology transfer.
• Radia Accelerator

Products and services

• Albion VCTs (Venture Capital Trust funds)

Quantifiable outcome

• Portfolio ARR exceeded $500m
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered flagship, core and minor.

• Harley Street Health DistrictflagshipStrategic or Co-development PartnerPartnership to accelerate access to breakthrough healthcare technologies by connecting London's world-renowned health district with UK healthtech spinouts, creating a new blueprint for rapid adoption and innovation.
• Radia AcceleratorcoreStrategic or Co-development PartnerCommunity-led initiative to support women founders at the inception stage of their journey, helping build a new generation of women-led SaaS unicorns. Supported 14 women founders.
• UN Principles for Responsible Investment (UN PRI)coreOthersAlbionVC is a signatory of UN PRI, committing to incorporate ESG issues into investment practice through six key principles.
• VentureESGminorOthersMember of VentureESG steering committee, a community-based non-profit initiative from VCs for VCs to push the industry on ESG best practice. Group includes 300 venture funds and 90 LPs globally.
• Investing in Women CodeminorOthersAlbionVC is a proud signatory of the Investing in Women Code, committing to adopt internal practices to improve female entrepreneurs' access to tools, resources and finance.
• Fair HQminorImplementation/ SI/ Consulting PartnerExpert consultancy engaged to establish diversity and inclusion practices including annual employee 'belonging survey', updated recruitment processes with CV blinding, and diversity tracking in hiring funnel.
• SupercriticalminorOthersBiochar carbon removal offset provider used by AlbionVC to offset all carbon put into the atmosphere in the previous 12 months.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Octopus Ventures: UK-based early-stage VC investing across similar software, healthtech, and deeptech verticals with comparable fund sizes and VCT structures. One of AlbionVC's closest UK peers in stage, sector, and LP base.
• Balderton Capital: London-headquartered early-stage VC backing UK and European technology founders across similar sector mixes. Overlapping stage, geography, and founder base make it a natural head-to-head peer.
• Notion Capital: UK VC specializing in B2B SaaS and fintech with similar ticket sizes; frequently co-invests alongside AlbionVC (Bound, OpenTrade, Treefera) and shares the same LP ecosystem.
• Episode 1: London-based seed-stage VC investing in UK software founders. Comparable check size, stage focus, and reliance on UK tech ecosystem make Episode 1 a direct comparable at the earliest stages of the funnel.
• LocalGlobe: UK seed investor with focus on mission-driven software founders; overlapping sector coverage (fintech, healthtech, climate) and shared London HQ market position AlbionVC and LocalGlobe as direct peers at pre-seed/seed.
• Parkwalk Advisors: UK university spinout specialist that co-invests with AlbionVC (Phasecraft, Scripta Therapeutics, Stanhope AI). Closest comparable in the deeptech/spinout sub-vertical and an active co-investor partner.
• Cambridge Enterprise (Seed Funds): University-affiliated seed investor backing Cambridge spinouts; co-invested with AlbionVC in Gigaton. Comparable deeptech focus and university spinout sourcing model.
• Oxford Science Enterprises: Oxford-based science and deeptech investor; co-led Scripta Therapeutics alongside AlbionVC's participation. Directly comparable in academic spinout origination and sector focus.
• Mercia Ventures: UK regional VC investing across software, healthtech, and deeptech; co-invested with AlbionVC in Flok Health and OpenTrade. Similar regional UK focus and stage.

Emerging players

• Planet A Ventures: Europe-focused climate-tech VC; co-invested with AlbionVC in Mondra and Gigaton. Comparable on the climate-tech sub-vertical though smaller and more thematic than AlbionVC's broader portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/AlbionVC
• LinkedInlinkedin.com/company/albionvc

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments171 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AlbionVC